FDA Inspection 1326702 — Novo Nordisk Pharmaceutical Industries, LP
The FDA completed an inspection of Novo Nordisk Pharmaceutical Industries, LP on June 30, 2026 in Petersburg, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 30, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Petersburg, VA (United States)